Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Oncology Based In-Vivo CRO Global Market Report 2025
Download Free Sample Buy Now
Global Oncology Based In-Vivo CRO Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Oncology Based In-Vivo CRO Global Market Report 2025

By Indication (Blood Cancer, Solid Tumors, Other Indications), By Model (Syngeneic Model, Xenograft, Patient Derived Xenograft (PDX), Other Models), By Application (Hospitals, Rehabilitation Centers) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Oncology Based In-Vivo CRO Market Overview

• Oncology Based In-Vivo CRO market size has reached to $1.39 billion in 2024

• Expected to grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%

• Growth Driver: Surging Cancer Prevalence Fuels Growth In The Oncology-Based In-Vivo CRO Market

• Market Trend: Oncology CRO Market Shifts Toward Personalized Models With Charles River Laboratories' Launch Of Oncomouse Platform

• North America was the largest region and fastest growing region.

What Is Covered Under Oncology Based In-Vivo CRO Market?

An oncology-based in-vivo contract research organization (CRO) refers to a company hired by another company to perform complete or partial steps of running a preclinical in-vivo study (testing or with living organisms such as animals, plants, or whole cells), such as designing, managing, monitoring, and analyzing in-vivo preclinical results for oncology drugs or devices.

The main indications of oncology-based in-vivo CRO are blood cancer, Solid Tumors, and other indications. Blood cancers refer to cancers originating from blood-forming tissues such as immune system cells, bone marrow, and others. Leukemia, lymphoma, and multiple myeloma are some of the blood cancer types. CROs offer in-vivo testing services using blood cancer-based Xenografts and other models to accelerate drug development research and help drug and device sponsors get market approval. The various models adopted by oncology-based in-vivo CRO are the syngeneic model, xenograft, patient-derived xenograft (PDX), and other models that are applied in hospitals and rehabilitation centers.

Oncology Based In-Vivo CRO Market Size and growth rate 2025 to 2029: Graph

What Is The Oncology Based In-Vivo CRO Market Size 2025 And Growth Rate?

The oncology based in-vivo cro market size has grown strongly in recent years. It will grow from$1.39 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing focus on oncology therapeutics, increasing incidence of cancer, shift towards personalized medicine, pharmaceutical industry growth, and demand for target-specific therapies

What Is The Oncology Based In-Vivo CRO Market Growth Forecast?

The oncology based in-vivo cro market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to emerging market opportunities, a shift towards immuno-oncology therapies, a rise in oncology clinical trials, precision medicine, and targeted therapies. Major trends in the forecast period include regenerative medicine and cell therapies, demand for faster drug development, digitalization and data analytics, focus on tumor microenvironment, and rise in biologics and immunotherapies.

The forecast of 10.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose challenges for U.S. clinical trials by raising costs for PDX mouse models (China) and microimaging scanners (Netherlands), potentially delaying oncology drug approvals and increasing research and development (R&D) expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Oncology Based In-Vivo CRO Market Segmented?

1) By Indication: Blood Cancer, Solid Tumors, Other Indications

2) By Model: Syngeneic Model, Xenograft, Patient Derived Xenograft (PDX), Other Models

3) By Application: Hospitals, Rehabilitation Centers

Subsegments:

1) By Blood Cancer: Leukemia, Lymphoma, Myeloma

2) By Solid Tumors: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Solid Tumors

3) By Other Indications: Neuroblastoma, Germ Cell Tumors, Sarcomas, Other Specific Indications

What Is Driving The Oncology Based In-Vivo CRO Market? Surging Cancer Prevalence Fuels Growth In The Oncology-Based In-Vivo CRO Market

The growing prevalence of cancer is expected to propel the growth of the oncology-based in-vivo CRO market going forward. Cancer refers to a group of diseases in which abnormal cells divide uncontrollably, go beyond their usual boundaries, originate in almost any organ or tissue of the body, and spread through the blood and lymph systems to other parts of the body. Treatment and diagnosis of cancer require innovative drugs and devices, which undergo different preclinical trials, clinical trials, and regulatory processes before they enter the market. An oncology in-vivo-based CRO is a company hired by a sponsor company that provides research services such as performing complete or partial steps of running a preclinical in-vivo study (testing or with living organisms such as animals, plants, or whole cells) before the drug or device is trialed in humans. With the increasing prevalence of cancer, the demand for innovative treatments and therapies has also increased, driving the growth of the oncology-based in-vivo CRO market. For instance, in April 2024, the American Cancer Society, a US-based non-profit organization, there were roughly 609,000 cancer-related deaths and 1.9 million new cancer cases identified in the country in 2022. An estimated 620,000 cancer deaths are anticipated, which would represent a little increase in mortality rates in 2024. The growing prevalence of cancer is driving the oncology-based in-vitro CRO market.

What Is Driving The Oncology Based In-Vivo CRO Market? Healthcare Expenditure's Impact Driving The Oncology-Based In-Vivo CRO Market

The rising healthcare expenditure is anticipated to drive the expansion of the oncology-based in-vivo CRO market in the future. Healthcare expenditure refers to spending on healthcare costs and represents the total amount of money spent on healthcare-related goods and services within a given healthcare system or economy. Healthcare expenditure plays a crucial role in supporting the development, accessibility, and for the oncology-based in-vitro CRO. For instance, in November 2022, according to the Canadian Institute for Health Information, a US-based not-for-profit organization, healthcare expenditure rose to 0.8%, which is $331 billion in 2022, and it was 7.6% in 2021. Therefore, rising healthcare expenditure is driving the growth of the oncology-based in-vivo CRO market.

Who Are The Major Players In The Global Oncology Based In-Vivo CRO Market?

Major companies operating in the oncology based in-vivo CRO market include Crown Bioscience, Charles River Laboratories International Inc., Taconic Biosciences Inc., The Jackson Laboratory, ICON plc., WuXi AppTec Inc., Eurofins Scientific SE, Labcorp Drug Development, Champion Oncology Inc., Xentech SAS, Thermo Fisher Scientific Inc., MI Bioresearch Inc., Clintec International Private Limited, Worldwide Clinical Trials Inc., Pharm-Olam LLC, Clinipace Clinical Research Private Limited, Covance Inc., Evotec SE, Living Tumor Laboratory, Oncodesign SA, Pharmaron Beijing Co. Ltd., Syngene International Limited, GenScript Biotech Corporation, Shanghai Medicilon Inc., Oncolys BioPharma Inc., Pharmalegacy Laboratories, Oncotest GmbH, Oncovision, Biocytogen LLC, Innovent Biologics Inc.

What Are The Key Trends Of The Global Oncology Based In-Vivo CRO Market? Oncology CRO Market Shifts Toward Personalized Models With Charles River Laboratories' Launch Of Oncomouse Platform

Major companies operating in the oncology-based in vivo CRO market are focusing on personalized oncology models to gain a competitive advantage. Personalized oncology models utilize patient-derived xenografts (PDXs) to create tailored treatment strategies, enhancing the relevance and efficacy of preclinical studies. For instance, in 2022, Charles River Laboratories, a U.S.-based life sciences company, launched its OncoMouse platform, which incorporates PDX technology for more accurate tumor modeling. This platform features high-throughput screening capabilities and real-time monitoring of tumor growth, allowing for rapid assessment of therapeutic responses. Additionally, it provides integrated data analytics to optimize treatment protocols based on individual patient profiles. These advancements signify a shift towards more effective and patient-centric approaches in cancer research.

What Are The Key Trends Of The Global Oncology Based In-Vivo CRO Market? Car T-Cell Therapies In The Oncology-Based In-Vivo CRO Market

Major companies operating in the oncology-based in vivo CRO market are focused on developing new solutions such as CAR T-cell therapies to gain a competitive edge in the market. CAR T-cell therapy is a form of immunotherapy that uses specially altered T cells to fight cancer. For instance, in May 2023, Seattle, a US-based Children's Hospital and Research Institute, launched BrainChild Bio to accelerate CAR T-cell therapies for children with brain tumors. The first pediatric brain tumors that BrainChild Bio would target with CAR T-cell therapy are diffuse intrinsic pontine gliomas (DIPG), an incurable childhood disease that develops in the brainstem. BrainChild Bio is a next-generation CAR T-cell treatment platform that incorporates synthetic technologies to maximize the use of CAR T-cell therapies for CNS malignancies. BrainChild Bio intends to apply its innovative CAR T-cell therapy to treat more adult and pediatric brain tumors that are challenging to cure, such as glioblastoma and brain metastases, after obtaining pediatric registration for DIPG.

Need data on a specific region in this market?
Request Regional Data

Oncology Based In-Vivo CRO Market Merger And Acquisition: ClinChoice Medical Development Strengthens Global Presence And Capabilities With Acquisition Of Cromsource S.R.L

In March 2023, ClinChoice Medical Development, a US-based contract research organization (CRO) that provides research services to accelerate drug and device approvals, acquired Cromsource S.r.l. for an undisclosed amount. Through this acquisition, ClinChoice Medical Development expands its operational capabilities with additional delivery hubs to complement its existing network in Europe and the US. Data science technology offerings in several areas, including risk-based monitoring and decentralized clinical trials, are expanded through acquisition. Cromsource S.r.l. is an Italy-based contract research organization that provides full-research services to the pharmaceutical, biotechnology, and medical device industries.

Regional Analysis For The Global Oncology Based In-Vivo CRO Market

North America was the largest region in the oncology-based in-vivo CRO market in 2024.North America is expected to be the fastest-growing region in the global oncology-based in-vivo CRO market report during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oncology Based In-Vivo CRO Market?

The oncology-based in-vivo CRO market includes revenues earned by entities by providing preclinical research services such as in-vivo testing via models such as Orthotopic tumor models, tumor passaging, tissue culture models, and others for oncology drugs and devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Oncology Based In-Vivo CRO Industry?

The oncology based in-vivo cro market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncology based in-vivo cro industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Oncology Based In-Vivo CRO Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.5 billion
Revenue Forecast In 2034 $2.27 billion
Growth Rate CAGR of 10.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Indication: Blood Cancer, Solid Tumors, Other Indications
2) By Model: Syngeneic Model, Xenograft, Patient Derived Xenograft (PDX), Other Models
3) By Application: Hospitals, Rehabilitation Centers Subsegments: 1) By Blood Cancer: Leukemia, Lymphoma, Myeloma
2) By Solid Tumors: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Solid Tumors
3) By Other Indications: Neuroblastoma, Germ Cell Tumors, Sarcomas, Other Specific Indications
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Crown Bioscience, Charles River Laboratories International Inc., Taconic Biosciences Inc., The Jackson Laboratory, ICON plc., WuXi AppTec Inc., Eurofins Scientific SE, Labcorp Drug Development, Champion Oncology Inc., Xentech SAS, Thermo Fisher Scientific Inc., MI Bioresearch Inc., Clintec International Private Limited, Worldwide Clinical Trials Inc., Pharm-Olam LLC, Clinipace Clinical Research Private Limited, Covance Inc., Evotec SE, Living Tumor Laboratory, Oncodesign SA, Pharmaron Beijing Co. Ltd., Syngene International Limited, GenScript Biotech Corporation, Shanghai Medicilon Inc., Oncolys BioPharma Inc., Pharmalegacy Laboratories, Oncotest GmbH, Oncovision, Biocytogen LLC, Innovent Biologics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Oncology Based In-Vivo CRO Market Characteristics

3. Oncology Based In-Vivo CRO Market Trends And Strategies

4. Oncology Based In-Vivo CRO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Oncology Based In-Vivo CRO Growth Analysis And Strategic Analysis Framework

5.1. Global Oncology Based In-Vivo CRO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Oncology Based In-Vivo CRO Market Growth Rate Analysis

5.4. Global Oncology Based In-Vivo CRO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Oncology Based In-Vivo CRO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Oncology Based In-Vivo CRO Total Addressable Market (TAM)

6. Oncology Based In-Vivo CRO Market Segmentation

6.1. Global Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood Cancer

Solid Tumors

Other Indications

6.2. Global Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Syngeneic Model

Xenograft

Patient Derived Xenograft (PDX)

Other Models

6.3. Global Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Rehabilitation Centers

6.4. Global Oncology Based In-Vivo CRO Market, Sub-Segmentation Of Blood Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Leukemia

Lymphoma

Myeloma

6.5. Global Oncology Based In-Vivo CRO Market, Sub-Segmentation Of Solid Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Other Solid Tumors

6.6. Global Oncology Based In-Vivo CRO Market, Sub-Segmentation Of Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neuroblastoma

Germ Cell Tumors

Sarcomas

Other Specific Indications

7. Oncology Based In-Vivo CRO Market Regional And Country Analysis

7.1. Global Oncology Based In-Vivo CRO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Oncology Based In-Vivo CRO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oncology Based In-Vivo CRO Market

8.1. Asia-Pacific Oncology Based In-Vivo CRO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oncology Based In-Vivo CRO Market

9.1. China Oncology Based In-Vivo CRO Market Overview

9.2. China Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oncology Based In-Vivo CRO Market

10.1. India Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oncology Based In-Vivo CRO Market

11.1. Japan Oncology Based In-Vivo CRO Market Overview

11.2. Japan Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oncology Based In-Vivo CRO Market

12.1. Australia Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oncology Based In-Vivo CRO Market

13.1. Indonesia Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oncology Based In-Vivo CRO Market

14.1. South Korea Oncology Based In-Vivo CRO Market Overview

14.2. South Korea Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oncology Based In-Vivo CRO Market

15.1. Western Europe Oncology Based In-Vivo CRO Market Overview

15.2. Western Europe Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oncology Based In-Vivo CRO Market

16.1. UK Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oncology Based In-Vivo CRO Market

17.1. Germany Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oncology Based In-Vivo CRO Market

18.1. France Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oncology Based In-Vivo CRO Market

19.1. Italy Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oncology Based In-Vivo CRO Market

20.1. Spain Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oncology Based In-Vivo CRO Market

21.1. Eastern Europe Oncology Based In-Vivo CRO Market Overview

21.2. Eastern Europe Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oncology Based In-Vivo CRO Market

22.1. Russia Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oncology Based In-Vivo CRO Market

23.1. North America Oncology Based In-Vivo CRO Market Overview

23.2. North America Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oncology Based In-Vivo CRO Market

24.1. USA Oncology Based In-Vivo CRO Market Overview

24.2. USA Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oncology Based In-Vivo CRO Market

25.1. Canada Oncology Based In-Vivo CRO Market Overview

25.2. Canada Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oncology Based In-Vivo CRO Market

26.1. South America Oncology Based In-Vivo CRO Market Overview

26.2. South America Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oncology Based In-Vivo CRO Market

27.1. Brazil Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oncology Based In-Vivo CRO Market

28.1. Middle East Oncology Based In-Vivo CRO Market Overview

28.2. Middle East Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oncology Based In-Vivo CRO Market

29.1. Africa Oncology Based In-Vivo CRO Market Overview

29.2. Africa Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oncology Based In-Vivo CRO Market Competitive Landscape And Company Profiles

30.1. Oncology Based In-Vivo CRO Market Competitive Landscape

30.2. Oncology Based In-Vivo CRO Market Company Profiles

30.2.1. Crown Bioscience Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Taconic Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. The Jackson Laboratory Overview, Products and Services, Strategy and Financial Analysis

30.2.5. ICON plc. Overview, Products and Services, Strategy and Financial Analysis

31. Oncology Based In-Vivo CRO Market Other Major And Innovative Companies

31.1. WuXi AppTec Inc.

31.2. Eurofins Scientific SE

31.3. Labcorp Drug Development

31.4. Champion Oncology Inc.

31.5. Xentech SAS

31.6. Thermo Fisher Scientific Inc.

31.7. MI Bioresearch Inc.

31.8. Clintec International Private Limited

31.9. Worldwide Clinical Trials Inc.

31.10. Pharm-Olam LLC

31.11. Clinipace Clinical Research Private Limited

31.12. Covance Inc.

31.13. Evotec SE

31.14. Living Tumor Laboratory

31.15. Oncodesign SA

32. Global Oncology Based In-Vivo CRO Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oncology Based In-Vivo CRO Market

34. Recent Developments In The Oncology Based In-Vivo CRO Market

35. Oncology Based In-Vivo CRO Market High Potential Countries, Segments and Strategies

35.1 Oncology Based In-Vivo CRO Market In 2029 - Countries Offering Most New Opportunities

35.2 Oncology Based In-Vivo CRO Market In 2029 - Segments Offering Most New Opportunities

35.3 Oncology Based In-Vivo CRO Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Oncology Based In-Vivo CRO Market, Sub-Segmentation Of Blood Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Oncology Based In-Vivo CRO Market, Sub-Segmentation Of Solid Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Oncology Based In-Vivo CRO Market, Sub-Segmentation Of Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Oncology Based In-Vivo CRO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Oncology Based In-Vivo CRO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Crown Bioscience Financial Performance
  • Table 78: Charles River Laboratories International Inc. Financial Performance
  • Table 79: Taconic Biosciences Inc. Financial Performance
  • Table 80: The Jackson Laboratory Financial Performance
  • Table 81: ICON plc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Oncology Based In-Vivo CRO Market, Sub-Segmentation Of Blood Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Oncology Based In-Vivo CRO Market, Sub-Segmentation Of Solid Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Oncology Based In-Vivo CRO Market, Sub-Segmentation Of Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Oncology Based In-Vivo CRO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Oncology Based In-Vivo CRO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Crown Bioscience Financial Performance
  • Figure 78: Charles River Laboratories International Inc. Financial Performance
  • Figure 79: Taconic Biosciences Inc. Financial Performance
  • Figure 80: The Jackson Laboratory Financial Performance
  • Figure 81: ICON plc. Financial Performance

Intestinal Fistula Treatment Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Read More About Intestinal Fistula Treatment Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Invasive Aspergillosis Therapeutics : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Invasive Aspergillosis Therapeutics : Market Forecast, Transformation, and Long-Term Trajectories

Iron Deficiency Anemia Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Iron Deficiency Anemia Growth Trajectory: Key Forecasts and Strategic Insights

Lewy Body Dementia Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Lewy Body Dementia Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

View Report

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

View Report

Pharma And Biotech CRM Software Global Market Report 2025 – By Technology (Artificial Intelligence Customer Relationship Management (CRM), Conventional Customer Relationship Management (CRM)), By Deployment (On-Premises,...

View Report

Artificial Intelligence In Oncology Global Market Report 2025 – By Component (Software Solutions, Hardware, Services), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types), By Cancer Type ...

View Report

Oncology Ablation Global Market Report 2025 – By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation), By Treatment (Surgical Ablation, Laparoscopic Ablation, Perc...

View Report

Interventional Oncology Devices Global Market Report 2025 – By Product (Embolization Devices, Ablation Devices, Support Devices), By procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial C...

View Report

Oncology Based In-Vivo CRO Global Market Report 2025 – By Indication (Blood Cancer, Solid Tumors, Other Indications), By Model (Syngeneic Model, Xenograft, Patient Derived Xenograft (PDX), Other Models), By Application (...

View Report

Oncology Devices Global Market Report 2025 – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy), By End User (Hospitals, Can...

View Report

Frequently Asked Questions

An oncology-based in-vivo contract research organization (CRO) refers to a company hired by another company to perform complete or partial steps of running a preclinical in-vivo study (testing or with living organisms such as animals, plants, or whole cells), such as designing, managing, monitoring, and analyzing in-vivo preclinical results for oncology drugs or devices. For further insights on this market, request a sample here

The market major growth driver - Surging Cancer Prevalence Fuels Growth In The Oncology-Based In-Vivo CRO Market. For further insights on this market, request a sample here

The oncology based in-vivo cro market size has grown strongly in recent years. It will grow from $1.39 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing focus on oncology therapeutics, increasing incidence of cancer, shift towards personalized medicine, pharmaceutical industry growth, and demand for target-specific therapies. The oncology based in-vivo cro market size is expected to see rapid growth in the next few years. It will grow to " $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to emerging market opportunities, a shift towards immuno-oncology therapies, a rise in oncology clinical trials, precision medicine, and targeted therapies. Major trends in the forecast period include regenerative medicine and cell therapies, demand for faster drug development, digitalization and data analytics, focus on tumor microenvironment, and rise in biologics and immunotherapies. For further insights on this market, request a sample here

The oncology based in-vivo cromarket covered in this report is segmented –
1) By Indication: Blood Cancer; Solid Tumors; Other Indications
2) By Model: Syngeneic Model; Xenograft; Patient Derived Xenograft (PDX); Other Models
3) By Application: Hospitals; Rehabilitation Centers Subsegments:
1) By Blood Cancer: Leukemia; Lymphoma; Myeloma
2) By Solid Tumors: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Other Solid Tumors
3) By Other Indications: Neuroblastoma; Germ Cell Tumors; Sarcomas; Other Specific Indications For further insights on this market, request a sample here

North America was the largest region in the oncology-based in-vivo CRO market in 2024.North America is expected to be the fastest-growing region in the global oncology-based in-vivo CRO market report during the forecast period. The regions covered in the oncology-based in-vivo CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the oncology based in-vivo cro market include Crown Bioscience, Charles River Laboratories International Inc., Taconic Biosciences Inc., The Jackson Laboratory, ICON plc., WuXi AppTec Inc., Eurofins Scientific SE, Labcorp Drug Development, Champion Oncology Inc., Xentech SAS, Thermo Fisher Scientific Inc., MI Bioresearch Inc., Clintec International Private Limited, Worldwide Clinical Trials Inc., Pharm-Olam LLC, Clinipace Clinical Research Private Limited, Covance Inc., Evotec SE, Living Tumor Laboratory, Oncodesign SA, Pharmaron Beijing Co. Ltd., Syngene International Limited, GenScript Biotech Corporation, Shanghai Medicilon Inc., Oncolys BioPharma Inc., Pharmalegacy Laboratories, Oncotest GmbH, Oncovision, Biocytogen LLC, Innovent Biologics Inc. . For further insights on this market, request a sample here.

Major trends in this market include Oncology CRO Market Shifts Toward Personalized Models With Charles River Laboratories' Launch Of Oncomouse Platform. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Oncology Based In-Vivo CRO Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon